1

Exhibit 99.01

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION
1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Immunotechnology Corporation (the
"Company") on Form 10-QSB for the period ending September 30, 2002 as filed
with the Securities and Exchange Commission on this date (the "Report"), I,
Mark A. Scharmann, Principal Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.


/S/ Mark A. Scharmann
Mark A. Scharmann
Principal Executive Officer
November 14, 2002